UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Link zum Volltext

Verfügbarkeit prüfen

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1580-1583

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Link zum Volltext

Verfügbarkeit prüfen

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4859-4861

Lønning, Per E

2008

Link zum Volltext

Verfügbarkeit prüfen

Endocrine effects of aromatase inhibitors

Journal of clinical oncology, 2010-02, Vol.28 (6), p.e101-e102

2010

Link zum Volltext

Verfügbarkeit prüfen

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Clinical cancer research, 2022-11, Vol.28 (21), p.4714-4723

2022

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

The New England journal of medicine, 2004-03, Vol.350 (11), p.1081-1092

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecular portraits of human breast tumours

Nature (London), 2000-08, Vol.406 (6797), p.747-752

2000

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Link zum Volltext

Verfügbarkeit prüfen

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

Clinical cancer research, 2005-01, Vol.11 (2), p.918s-924s

Per E. Lønning

2005

Link zum Volltext

Verfügbarkeit prüfen

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Genome Biology, 2014-09, Vol.15 (9), p.447-447, Article 447

2014

Link zum Volltext

Verfügbarkeit prüfen

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Nature medicine, 1996-07, Vol.2 (7), p.811-814

1996

Link zum Volltext

Verfügbarkeit prüfen

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors and inactivators for breast cancer therapy

Drugs & aging, 2002, Vol.19 (4), p.277-298

LØNNING, Per E

2002

Link zum Volltext

Verfügbarkeit prüfen

The Potential for Aromatase Inhibition in Breast Cancer Prevention

Clinical cancer research, 2001-12, Vol.7 (12), p.4423s

2001

Link zum Volltext

Verfügbarkeit prüfen

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Clinical cancer research, 2005-01, Vol.11 (2 Pt 2), p.861s-864s

2005

Link zum Volltext

Verfügbarkeit prüfen

Influence of Aromatase Inhibitors on Plasma Total Homocysteine in Postmenopausal Breast Cancer Patients

Clinical chemistry (Baltimore, Md.), 1999-02, Vol.45 (2), p.252-256

1999

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Clinical cancer research, 2005-01, Vol.11 (2), p.878s-883s

2005

Link zum Volltext

Verfügbarkeit prüfen

Genome sequencing for personalized cancer treatment

Tidsskrift for den Norske Lægeforening, 2012-11, Vol.132 (21), p.2406-2408

2012

Link zum Volltext

Verfügbarkeit prüfen

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Journal of clinical oncology, 2002-07, Vol.20 (13), p.3039-3040

2002

Link zum Volltext

Verfügbarkeit prüfen

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Clinical cancer research, 1996-09, Vol.2 (9), p.1515-1521

1996

Link zum Volltext

Verfügbarkeit prüfen

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Clinical cancer research, 1998-09, Vol.4 (9), p.2125-2128

1998

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma

Cancer, 1999-02, Vol.85 (4), p.891-898

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

Clinical pharmacology and therapeutics, 1984-12, Vol.36 (6), p.796-802

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionPublisher or Other Site

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(45)

Sprache

Englisch
(44)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Incomplete Estrogen Suppression With Gonadotropin-Releasing Hormone Agonists May Reduce Clinical Efficacy in Premenopausal Women With Early Breast Cancer

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?

Endocrine effects of aromatase inhibitors

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Molecular portraits of human breast tumours

Long-Term Follow-Up of the Intergroup Exemestane Study

Exemestane for Breast Cancer Prevention: A Feasible Strategy?

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Aromatase inhibitors and inactivators for breast cancer therapy

The Potential for Aromatase Inhibition in Breast Cancer Prevention

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement

Influence of Aromatase Inhibitors on Plasma Total Homocysteine in Postmenopausal Breast Cancer Patients

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Genome sequencing for personalized cancer treatment

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients

Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

Aktive Filter

Suchergebnisse filtern